Biotech Penny Stocks to Watch: Key Takeaways
- This week biotechs are moving on news and technical chart patterns you MUST know!
- Why I’m still watching one of last week’s picks that broke out to new 52-week highs.
- Learn one of my favorite strategies in my no-cost webinar happening tonight — reserve your seat below…
Join Me September 1 at 8 p.m. Eastern for my NO-COST Weekend Profits Webinar
I’m watching 7 biotech penny stocks for potential breakouts or dip buys. Technical patterns can create massive moves — with or without a news catalyst. Find out what’s moving on news and learn the technical patterns I’m watching for in these biotechs.
- Qualigen Therapeutics, Inc. (NASDAQ: QLGN … Read our full analysis here.)
- Sonnet BioTherapeutics Holdings, Inc. (SONN … Read our full analysis here.)
- Cellect Biotechnology Ltd. (NASDAQ: APOP … Read our full analysis here.)
- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS … Read our full analysis here.)
- Cybin Inc. (AMEX: CYBN … Read our full analysis here.)
- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL … Read our full analysis here.)
- Immutep Limited (NASDAQ: IMMP … Read our full analysis here.)
Working on a badass new blog post for https://t.co/DI3pEzRYmp with the 6 top lessons I learned from hanging out with 6 of my top millionaire students the past few days here in Italy, let’s see if anyone can guess the most important rules they trade with?!?
— Timothy Sykes (@timothysykes) August 31, 2021
Top Biotech Penny Stocks to Watch
These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.
Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…
- If you’re new to penny stocks, start here with this FREE online guide.
- Ready to learn how to build your own stock watchlist? This post is for you.
- Discover how I find all the stocks on my watchlists here.
How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.
And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7…
Or try it with the Breaking News Chat for only $17!
Now, let’s get to the top biotech penny stocks to watch this week…
Biotech Penny Stocks #1: Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
QLGN develops therapies for cancer and infectious diseases.
The stock spiked over 25% on August 31 with no news. It traded higher than average volume and recently bounced off its 52-week lows.
Unless there’s a news catalyst to push it higher, I’ll watch for a panic dip buy.
Biotech Penny Stocks #2: Sonnet BioTherapeutics Holdings, Inc. (SONN)
SONN is a clinical-stage biotech that develops cancer treatments.
In after-hours on August 30 the company announced it selected a novel development candidate to target melanoma and renal cancers.
Sonnet founder and CEO Pankaj Mohan said, “Following our recently completed $30 million financing, we are excited to have identified this latest bispecific candidate, which is scheduled to enter the next stages of its development during the fourth quarter of 2021, with the objective of filing an IND in the second half of 2022.”
Read the full press release here.
The stock gapped up after the news but didn’t hold its gains. It’s a choppy stock — not my favorite to trade. I’ll watch for a potential dip buy into any big morning panic.
Biotech Penny Stocks #3: Cellect Biotechnology Ltd. (NASDAQ: APOP)
APOP develops technologies to select stem cells for regenerative therapies.
The stock had a multi-month breakout on August 30. The next day it broke above $5 and continued higher.
It’s another choppy stock with no news. I’ll watch for a morning panic dip buy.
Biotech Penny Stocks #4: Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS)
PIRS develops drugs to treat inflammatory diseases and tumors.
It’s a multi-day runner that broke out to new 52-week highs on August 30. That’s when the company dropped an SEC filing…
The Form 8-K included a copy of Dr. Vanessa Neiens’ presentation at the IPF Summit titled, “Inhaled Biologics: The Application of Anticalin Proteins in the Treatment of IPF.”
Read the SEC filing and presentation here.
The next day the stock consolidated around the breakout level. It’s another one I’ll watch for a panic dip buy.
Learn how to read SEC filings here.
Biotech Penny Stocks #5: Cybin Inc. (AMEX: CYBN)
CYBN’s a biotech that develops psychedelic treatments for neurological conditions.
The stock’s been in an uptrend since the company announced it filed two international patent applications on August 19.
It’s currently trading in the high $2s and its 52-week high is $3.38. I’ll watch for a potential breakout, but I’d like to see another catalyst bring in high volume.
Biotech Penny Stocks #6: Adial Pharmaceuticals, Inc. (NASDAQ: ADIL)
ADIL develops treatments for addiction and related disorders.
It’s on my watchlist for the third straight week. Last week I was watching for a breakout over $3.50. It broke out, continued to climb, and made new 52-week highs of $4.53. (Past performance is not indicative of future results.)
On August 31 the company announced it exceeded its enrollment target for the Phase 3 trial of its treatment for alcohol use disorder.
The stock’s been consolidating between $4 and $4.50 for a few days. I’ll watch for it to choose a direction before planning a trade. A breakout over $4.53 could create more upside. Or a breakdown below $4 could offer a panic dip buy opportunity.
Biotech Penny Stocks #7: Immutep Limited (NASDAQ: IMMP)
IMMP develops immunotherapies for cancer and autoimmune disease.
On August 31 the company announced that its Chinese partner is expanding its clinical trial pipeline.
“The new trial is expected to commence in the first half of calendar year 2022. The new trial builds on the latest promising data presented by Immutep at ASCO 2021 and on EOC’s previously announced Phase II trial evaluating efti in combination with chemotherapy in metastatic breast cancer patients.”
Read the full press release here.
The stock had a multi-month breakout over $4 after the news. I’ll watch it for more potential upside, but I’d like to see it trade more volume.
Get the List of Penny Stocks I’m Watching Delivered to Your Inbox
Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.
I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!
👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.
Conclusion
Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…
They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.
If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…
In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.
If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?
What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!
Disclaimers
*Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. Most who receive free or paid content will make little or no money because they will not apply the skills being taught. Any results displayed are exceptional. We do not guarantee any outcome regarding your earnings or income as the factors that impact such results are numerous and uncontrollable.
**Tim Sykes has a minority ownership stake in StockstoTrade.com.
The post Top Biotech Penny Stocks to Watch — September 1, 2021 appeared first on Timothy Sykes.